期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
肠源性腹膜透析相关性腹膜炎治疗失败的危险因素:多中心回顾性研究
1
作者 于梦园 杨立明 +6 位作者 朱学研 张晓暄 刘声茂 谢舜昀 倪册 庄小花 崔文鹏 《中华肾病研究电子杂志》 2023年第3期127-133,共7页
目的探讨肠源性腹膜透析相关性腹膜炎(PDAP)治疗失败的危险因素。方法回顾性收集2013年至2019年吉林省4家三甲医院PDAP患者临床资料,按照PDAP的致病菌类型,将研究对象分为肠源性PDAP组(284例)和非肠源性PDAP组(519例)。采用广义估计方程... 目的探讨肠源性腹膜透析相关性腹膜炎(PDAP)治疗失败的危险因素。方法回顾性收集2013年至2019年吉林省4家三甲医院PDAP患者临床资料,按照PDAP的致病菌类型,将研究对象分为肠源性PDAP组(284例)和非肠源性PDAP组(519例)。采用广义估计方程(GEE)比较两组患者的临床资料、初始疗效、当次PDAP治疗结果以及肠源性PDAP治疗失败的危险因素。结果本研究共纳入803例次PDAP,其中肠源性PDAP组为284例次,大肠埃希菌最多,为100例次(35.21%)。与非肠源性PDAP组相比,肠源性PDAP组的女性占比较高(55.99%和47.21%,P=0.043),且原发病为糖尿病肾病的比例较高(16.96%和11.27%,P=0.029)。两组患者在年龄、血红蛋白、血清白蛋白水平等方面均未见明显差异(均P>0.05)。与非肠源性PDAP组相比,肠源性PDAP组初始疗效和当次治疗结果均较差(均P<0.001)。多因素GEE分析显示,长透析龄、生活在农村、低血清白蛋白,以及肺炎克雷伯杆菌、铜绿假单胞菌、真菌及混合菌感染均为肠源性PDAP治疗失败的独立危险因素(P<0.05)。结论肠源性PDAP的治疗效果比非肠源性PDAP差。长透析龄、农村生活、低血清白蛋白水平及肺炎克雷伯杆菌、铜绿假单胞菌、真菌及混合菌感染是肠源性PDAP治疗失败的独立危险因素。 展开更多
关键词 腹膜透析 腹膜透析相关性腹膜炎 肠源菌 危险因素
原文传递
Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels 被引量:6
2
作者 Junxiang Hao Baoshuai Bai +10 位作者 Zheng Ci Jincheng Tang Guanhuai Hu Chengxiang Dai mengyuan yu Meng Li Wei Zhang Yixin Zhang Wenjie Ren yujie Hua Guangdong Zhou 《Bioactive Materials》 SCIE 2022年第8期97-109,共13页
Physiological repair of large-sized bone defects is great challenging in clinic due to a lack of ideal grafts suitable for bone regeneration.Decalcified bone matrix(DBM)is considered as an ideal bone regeneration scaf... Physiological repair of large-sized bone defects is great challenging in clinic due to a lack of ideal grafts suitable for bone regeneration.Decalcified bone matrix(DBM)is considered as an ideal bone regeneration scaffold,but low cell seeding efficiency and a poor osteoinductive microenvironment greatly restrict its application in large-sized bone regeneration.To address these problems,we proposed a novel strategy of bone regeneration units(BRUs)based on microgels produced by photo-crosslinkable and microfluidic techniques,containing both the osteogenic ingredient DBM and vascular endothelial growth factor(VEGF)for accurate biomimic of an osteoinductive microenvironment.The physicochemical properties of microgels could be precisely controlled and the microgels effectively promoted adhesion,proliferation,and osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs)in vitro.BRUs were successfully constructed by seeding BMSCs onto microgels,which achieved reliable bone regeneration in vivo.Finally,by integrating the advantages of BRUs in bone regeneration and the advantages of DBM scaffolds in 3D morphology and mechanical strength,a BRU-loaded DBM framework successfully regenerated bone tissue with the desired 3D morphology and effectively repaired a large-sized bone defect of rabbit tibia.The current study developed an ideal bone biomimetic microcarrier and provided a novel strategy for bone regeneration and large-sized bone defect repair. 展开更多
关键词 Microgels Large-sized bone defect repair Bone regeneration units PHOTO-CROSSLINKING Decalcified bone matrix
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部